PATENT CLAIM ANALYSIS

Application Number: 16014607
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "274000"]

Abstract:
Described herein are PPARα agonists, including, but not limited to, endocannabinoids that can be used for treatment of a neuropsychiatric disorder and/or symptom thereof. Also described herein are pharmactiutical formulations containing an effective amount of a PPARα agonists, including but not limited to endocannabinoids, where the effective amount is effective for treating a neuropsychiatric disorder and/or symptom thereof. Also described herein are methods of treating a neuropsychiatric disorder and/or a symptom thereof in a subject in ned thereof.

Claim (Index 15):
A pharmaceutical formulation comprising:\n a therapeutically effective amount of a PPAR\u03b1 agonist to treat post-traumatic stress disorder in a subject in need thereof.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 2.04762
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15012471', '15996764', '11576125', '13124330', '13105470']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7374227657140305
- 35 USC 102 Novelty (BERT): 0.5080844362321065
- Combined Prediction Score: 0.7144889327658381
- Mean Citation Score: 202.900754
- Max Citation Score: 214.83687
- Similarity Product: 124.05627800348282

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test